Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment
ACS Nano · 24.03.2026 · 20 (11) · 9105-9121
DOI: 10.1021/acsnano.5c16693 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 09.03.2026. Verfasst von Zhiqiang Zhao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Asthma, Nanoparticles, Mucin 5AC, RNA, Small Interfering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Liaoning Revitalization Talents Program, Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Beijing Key Laboratory of Molecular Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China.
- Beijing Tide Pharmaceutical Co., Ltd., Beijing 100176, China.
- University of North Carolina, Chapel Hill, North Carolina 27599, United States.
ORCID-Profile: Xueguang Lu, Lei Miao, Cong Luo
Förderung
- National Key Research and Development Program of China
- Liaoning Revitalization Talents Program
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
- Project of China-Japan Joint International Laboratory of Advanced Drug Delivery System Research and Translation of Liaoning Province
Zitieren
APA
Zhao, Z., Shan, X., Wang, W., Cao, C., Chen, D., Chu, L., Zeng, Y., Liu, Y., Yang, Y., Wu, Y., Zhao, Y., Chen, J., Wang, Z., Liu, X., Chen, Y., Lu, X., Zhou, J., Miao, L., & Luo, C. (2026). Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment. ACS Nano, 20(11), 9105-9121. https://doi.org/10.1021/acsnano.5c16693
Vancouver
Zhao Z, Shan X, Wang W, Cao C, Chen D, Chu L, et al. Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment. ACS Nano. 2026;20(11):9105-9121. doi:10.1021/acsnano.5c16693
BibTeX
@article{Zhao2026,
author = {Zhao, Zhiqiang and Shan, Xinzhu and Wang, Weixue and Cao, Changdi and Chen, Dian and Chu, Lanhe and Zeng, Yan and Liu, Yunxuan and Yang, Yue and Wu, Yun and Zhao, Yanping and Chen, Junhe and Wang, Zhenfan and Liu, Xiaojuan and Chen, Yahong and Lu, Xueguang and Zhou, Jian and Miao, Lei and Luo, Cong},
title = {Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {11},
pages = {9105--9121},
doi = {10.1021/acsnano.5c16693}
}
EUVIMED